Zevra Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ZVRA Nasdaq 2834 zevra.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Zevra Therapeutics, Inc.

Zevra Therapeutics to Present at the J.P. Morgan 44th Annual Healthcare Conference - Jan 8th, 2026 5:30 am
Zevra Therapeutics Executes Distribution Agreement to Broaden Access to MIPLYFFA® for the Treatment of Niemann-Pick Disease Type C (NPC) - Dec 29th, 2025 5:30 am
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - Dec 28th, 2025 10:46 am
Is Zevra Therapeutics Attractively Priced After Recent Rare Disease Pipeline Progress? - Dec 14th, 2025 3:04 am
Is Zevra Therapeutics (ZVRA) Undervalued After Its Recent Share Price Pullback? - Dec 13th, 2025 9:07 pm
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Dec 12th, 2025 2:30 pm
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - Dec 2nd, 2025 5:30 am
Zevra Therapeutics, Inc. Announces CFO Transition - Nov 20th, 2025 2:05 pm
XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements - Nov 12th, 2025 5:30 am
Analysts Have Lowered Expectations For Zevra Therapeutics, Inc. (NASDAQ:ZVRA) After Its Latest Results - Nov 8th, 2025 7:15 am
Zevra Therapeutics Inc (ZVRA) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Nov 5th, 2025 10:03 pm
Zevra Therapeutics (ZVRA) Reports Q3 Loss, Lags Revenue Estimates - Nov 5th, 2025 3:50 pm
Zevra Therapeutics: Q3 Earnings Snapshot - Nov 5th, 2025 2:48 pm
Zevra Reports Third Quarter 2025 Financial Results and Corporate Update - Nov 5th, 2025 2:05 pm
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) is definitely on the radar of institutional investors who own 50% of the company - Oct 30th, 2025 5:22 am
Zevra Therapeutics to Participate in the Guggenheim Healthcare Innovation Conference - Oct 29th, 2025 5:30 am
Zevra Therapeutics Announces Details for Q3 2025 Financial Results Call - Oct 27th, 2025 5:30 am
Zevra Therapeutics (ZVRA) Surges 12.3%: Is This an Indication of Further Gains? - Oct 16th, 2025 6:55 am
Zevra Therapeutics (ZVRA): Evaluating Valuation Following Insider Buying and Sustained Revenue Growth - Oct 9th, 2025 11:10 pm
Zevra Therapeutics Stock Sees Healthy RS Rating Jump To 73 - Oct 6th, 2025 11:04 am